Portage Biotech Quote - PRTG

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

6.82

Bid

6.72

Offer

7.30

Volume

27,730

6.6601 Day's Range 7.13

2.098 52 Week Range 58.60

Market Cap

7.152M

Previous Close

6.79

Open

6.84

Last Trade

6.83

Last Trade Time

Financial Volume

US$ 192,813

VWAP

6.9532

Average Volume (3m)

2,147,941

Shares Outstanding

1,048,614

Dividend Yield

PE Ratio

-0.10

Earnings Per Share (EPS)

-71.85

Revenue

Net Profit

-75.34M

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets ... Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. Show more

Sector

Pharmaceutical Preparations

Industry

Crude Petroleum & Natural Gs

Website

www.portagebiotech.com/

Headquarters

Road Town, Tortola, Vgb

Founded

2012

Portage Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRTG. The last closing price for Portage Biotech was US$6.79. Over the last year, Portage Biotech shares have traded in a share price range of US$ 2.098 to US$ 58.60.

Portage Biotech currently has 1,048,614 shares in issue. The market capitalisation of Portage Biotech is US$7.12 million. Portage Biotech has a price to earnings ratio (PE ratio) of -0.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.97	16.5811965812	5.85	8.118	5.31	121565	7.03543048	CS
4	3.1233	84.4888684502	3.6967	23.01	3.56	2723581	9.79586135	CS
12	3.122	84.42401298	3.698	23.01	2.098	2147941	7.28262014	CS
26	-3.34	-32.874015748	10.16	23.01	2.098	1391561	6.5506503	CS
52	-41.18	-85.7916666667	48	58.6	2.098	724829	6.95418393	CS
156	-395.18	-98.3034825871	402	479.8	2.098	259169	16.00302613	CS
260	-743.18	-99.0906666667	750	899.526	2.098	220951	30.42142672	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAMPCAMP4 Therapeutics Corporation	10.75 (2,587.50%)	378.47k
TWGTop Wealth Group Holding Ltd	US$ 7.14 (233.64%)	154.23M
NIVFNewGenIvf Group Ltd	US$ 0.98 (63.42%)	58.51M
ATIFATIF Holdings Ltd	US$ 1.235 (58.33%)	3.85M
VERBVerb Technology Company Inc	US$ 7.91 (51.82%)	15.55M
BYUBAIYU Holdings Inc	US$ 0.299 (-35.28%)	11.11M
TURBTurbo Energy SA	US$ 2.1511 (-29.01%)	3.2M
SMSTDefiance Daily Target 1.5X Short MSTR ETF	US$ 7.898 (-23.62%)	993.33k
VEEAVeea Inc	US$ 3.27 (-23.24%)	284.95k
INHDInno Holdings Inc	US$ 3.74 (-22.41%)	257.75k
JTAIJet AI Inc	US$ 0.1009 (23.50%)	340.09M
CDTConduit Pharmaceuticals Inc	US$ 0.116 (13.28%)	270.97M
NVDANVIDIA Corporation	US$ 134.80 (-0.01%)	170.27M
LUXHLuxUrban Hotels Inc	US$ 0.0532 (5.35%)	165.94M
TWGTop Wealth Group Holding Ltd	US$ 7.14 (233.64%)	154.23M